Biomarkers for Allergy, Asthma & Clinical Immunology
A biological marker is a physical sign or laboratory measurement that can function as a sign of biological or pathophysiological processes or as a riposte to a therapeutic intervention. Determining IgE of IgG in serum has been proved to be too unresponsive and too non-specific to identify individuals with sensitization, with and without clinical symptoms.
The biomarkers market is projected to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, growing at a CAGR of 13.8% during the forecast period (2016–2021). The biomarkers market is segmented on the basis of product, type, application, disease indication, and region. On the basis of product, the biomarkers market is segmented into consumables, services, and software. The consumables segment is estimated to account for the largest share of the global biomarkers market in 2016. The large share of this segment is primarily attributed to the lower price of consumables than that of screening and automation instruments.